Cause or cure? Review of dupilumab and alopecia areata

J Am Acad Dermatol. 2023 Mar;88(3):651-653. doi: 10.1016/j.jaad.2019.06.010. Epub 2019 Jun 13.

Authors

Dustin H Marks¹, Natasha Mesinkovska², Maryanne M Senna³

Affiliations

¹ Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
² Department of Dermatology, University of California, Irvine, California.
³ Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: msenna@partners.org.

PMID: 31391150
DOI: 10.1016/j.jaad.2019.06.010

No abstract available

Publication types

Letter

MeSH terms

Alopecia Areata*
Antibodies, Monoclonal, Humanized
Humans

Substances

dupilumab
Antibodies, Monoclonal, Humanized

Supplementary concepts

Diffuse alopecia